| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |